Drug Candidate Marketplace

Drug Candidate Marketplace lists the information of drug candidates, therapeutic targets and drug discovery technologies. Visitors can use search functions based on the interests and needs. If you have a drug candidates, therapeutic targets and drug discovery technologies that you are interested in and would like to gain more information, please contact us by clicking the inquiry button. After consenting to the terms of condition and use of our services, the requested information will be provided to you.

Date Candidate Mechanism of action Indication Route Development stage Note
03/26/18 GEM007 Vaccine Anthrax Oral Discovery~ Preclinical A cost-effective and safer vaccine that would produce immunity to anthrax with fewer doses Contact
03/26/18 GEM006 Bacterial NADH production inhibitor Bacterial infection Discovery~ Preclinical Inhibits synthesis of NADH in bacteria, but not in humans and expected to be used for treatment of multi-drug resistant pathogens Contact
03/26/18 GEM005 Androgen receptor down-regulator Prostate cancer Discovery~ Preclinical Decreases androgen receptor expression or function as well as androgen synthesis Contact
03/26/18 GEM004 Actin polymerization blocker Cancer Discovery Blocks actin polymerization by targeting an actin-associated protein and inhibits infiltration and metastasis Contact
01/10/18 GEM003 Selective glucocorticoid receptor agonist RA/OA Local Preclinical Expected to reduce unfavorable responses of glucocorticoids by selectivity of action (transrepression>transactivation) Contact
01/10/18 GEM002 Kappa-opioid receptor agonist Pain/Itching Oral Preclinical Developed for pain, but discontinued because of company strategy. Contact
01/10/18 GEM001 TRPV-1 agonist Rheumatoid Arthritis Oral Phase 2a Potently inhibits TNF-a production by oral administration Contact